# Corrigendum: Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials

**Authors:** An Wang, Mengqi Chen, Qi Zhuang, Lihua Guan, Weiping Xie, Lan Wang, Wei Huang, Zhaozhong Cheng, Shiyong Yu, Hongmei Zhou, Jieyan Shen

PMC · DOI: 10.3389/fcvm.2024.1371699 · Frontiers in Cardiovascular Medicine · 2024-02-21

## Full-text entities

- **Diseases:** pulmonary arterial hypertension (MESH:D000081029)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10916790/full.md

---
Source: https://tomesphere.com/paper/PMC10916790